Adding 3D Total Body Photography to Usual Care Increases Rate of Skin Excisions
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 26, 2025 -- The addition of three-dimensional (3D) total-body photography (TBP) and sequential digital dermoscopy imaging (SDDI) via teledermatology to usual care increases the number and rate of skin excisions, according to a study published online March 26 in JAMA Dermatology.
H. Peter Soyer, M.D., from the Frazer Institute at the University of Queensland Dermatology Research Centre in Brisbane, Australia, and colleagues examined clinical outcomes between 314 patients at high risk for melanoma receiving usual clinical care (156 participants) versus usual care plus 3D TBP and SDDI (158 participants) every six months via teledermatology in a randomized clinical trial.
The researchers found that the mean number of lesions of any type excised per person was significantly higher in the intervention group versus control group (5.73 versus 3.99). Compared with the control group, fewer melanomas were detected in the intervention group (24 [35 percent] versus 43 [64 percent]), with a lower incidence rate (2.03 versus 3.62). The number of melanomas diagnosed per person at the 12-month follow-up did not differ significantly between the groups (0.08 and 0.16 in the intervention and control groups, respectively; P = 0.08). The hazard ratio for risk of subsequent melanomas was 0.63 (95 percent confidence interval, 0.34 to 1.14; P = 0.13). The number of keratinocyte cancers diagnosed at 12-month follow-up was 0.86 and 0.42 in the intervention and control groups, respectively (P = 0.01). The hazard ratio for risk of subsequent keratinocyte cancers was 2.08 (95 percent confidence interval, 1.33 to 3.27; P < 0.001). The average benign lesion excision rate at one year was 2.01 and 1.39 in the intervention and control groups, respectively (P = 0.02). The hazard ratio for risk of subsequent benign lesion excisions was 1.50 (95 percent confidence interval, 1.16 to 1.93; P < 0.001).
"Adding sequential 3D TBP-SDDI skin examinations to a patient's usual care in a teledermatology setting led to an increase in excisions among patients at high risk for melanoma," the authors write.
Several authors disclosed ties to the medical device and medical technology industries; one author holds a related patent.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-27 06:00
Read more

- Federal Addiction And Mental Health Agency Faces Major Staff Cuts
- AAN: Over-the-Counter Pain Relivers Tied to Fewer Concussion Symptoms
- Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial
- New Data on Investigational Therapy Doxecitine and Doxribtimine for Thymidine Kinase 2 Deficiency Presented at Muscular Dystrophy Association (MDA) 2025 Conference
- AAD: Ivarmacitinib 4 mg, 8 mg Efficacious for Adults With Severe Alopecia Areata
- FDA Approves TNKase (tenecteplase) for the Treatment of Acute Ischemic Stroke in Adults
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions